Bausch + Lomb
02.13.19
Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible Hydra-PEG Custom Contact Lens CoatingSource: Bausch + Lomb
02.04.19
Bausch + Lomb Launches Sightmatters.com to Help People Living With AMDSource: Bausch + Lomb
01.03.19
Bausch + Lomb Announces Health Canada Approval Of Vyzulta for the Treatment of GlaucomaSource: Bausch + Lomb
12.06.18
Bausch + Lomb Receives FDA Clearance For Ultra Multifocal For Astigmatism Contact LensesSource: Bausch + Lomb
12.04.18
Bausch + Lomb Announces Exclusive Agreement with Modulight to Develop New Photodynamic LaserSource: Bausch + Lomb
10.24.18
Bausch + Lomb to Launch First-in-Class Surgical Support Applications for Stellaris Elite on IBM CloudSource: Bausch + Lomb
09.05.18
Phase 3 Trial of Bausch + Lomb’s Loteprednol Etabonate Drug Candidate Meets Primary Efficacy EndpointsSource: Bausch Health Companies
08.27.18
Bausch + Lomb Launches Expanded Parameters of Biotrue ONEday for Astigmatism Contact LensesSource: Bausch + Lomb